What is the market doing?
What the tape says about ARWR
Arrowhead Pharmaceuticals, Inc. is +455% over the past year while the S&P 500 is +23%: 432 points ahead of the market.
+455%
1-year return · S&P 500 +23%
- vs 200-day average
- +33%
vs 200-day average · a clear uptrend
- RSI (14)
- 60
RSI (14) · neutral
- Below its 52-week high
- −0.60%
Below its 52-week high
Details›
- Last close2026-08-26
- $89.07
- 1 monthS&P 500 +3.7%
- +2.7%
- 1 yearS&P 500 +23%
- +455%
- 5 yearsS&P 500 +87%
- +31%
- vs 50-day average$80.92
- +10%
- 52-week high
- $89.61
- 52-week low
- $16.42
- Annualised volatility
- 67%
| Year | Return |
|---|---|
| 2026 (year to date) | +34% |
| 2025 | +253% |
| 2024 | −39% |
| 2023 | −25% |
| 2022 | −39% |
| 2021 | −14% |
| 2020 | +21% |
| 2019 | +411% |
| 2018 | +237% |
| 2017 | +137% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +5.4% |
| Feb | 10 | 4 of 10 | +0.93% |
| Mar | 10 | 2 of 10 | −11% |
| Apr | 10 | 5 of 10 | +3.4% |
| May | 10 | 5 of 10 | +8.7% |
| Jun | 10 | 9 of 10 | +12% |
| Jul | 11 | 7 of 11 | +5.1% |
| Aug | 11 | 6 of 11 | +8.1% |
| Sep | 10 | 5 of 10 | +8.6% |
| Oct | 10 | 5 of 10 | +2.6% |
| Nov | 10 | 6 of 10 | +7.7% |
| Dec | 10 | 6 of 10 | +6.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.